Vestagen raises $7M

What does Vestagen do?

Vestagen, is a medical tech firm developing and marketing high performance apparel. This company is involved in developing, manufacturing and marketing textile products and technologies. It has exclusive North American rights for its patented Swiss technologies for medical textiles which can be adapted for many uses and apps, from the athletic apparel to medical uniforms.  This medical technology company is developing and marketing high performance apparel for the healthcare and many other demanding industries.

How much Vestagen was funded?

Vestagen raised $7M on February 8, 2016 from HealthQuest Capital and Advent Life Sciences.

Previous funding

• $8.25M in an undisclosed round on August 27, 2013 from Alliance Healthcare Investment Fund, V-Ten Capital and Advent Life Sciences
• $7.3M in Series A on December 10, 2013 from Sofinnova Ventures and Advent Life Sciences
• $3.3M on September 9, 2015 from Advent Life Sciences and HealthQuest Capital

What is next for Vestagen?

The company has named Bill Bold the CEO and as a part of the board of directors in the company. The proceeds of the latest funding will be used for commercializing VESTEX, the 1^st in a new class of active barrier technologies which combines antimicrobial, fluid repellent and breathability properties.  It is the only daily use textile proven to decrease the harmful contaminants on clothes in a hospital setting. It serves the aim of lowering the risk of spreading pathogens which are dangerous in hospitals. The company also has plans of expanding its product line and filing for the FDA review of VESTEX.

More about Vestagen

Vestagen was founded in 2009 by Ben Favret. It has its headquarters in Orlando, FL. The company is led by president and CEO Favret, who is an industry veteran who has spent over 20 successful years in the garment production by approved licensees.